No Benefit Found for High-Dose Vitamin C Infusions in Sepsis, ARDS
No differences seen versus placebo in organ dysfunction scores, biomarkers of inflammation or vascular injury
Elderly Who Start Thiopurine Tx for IBD Have Higher Risk for AEs
Advanced age, female gender are independent risk factors for adverse events
Uptitration of Drugs Varies With Target Dosage in Chronic HF
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Marine Omega-3 Supplements May Lower CVD Risk
Updated meta-analysis shows lower risks for MI, CHD death, total CHD, CVD death, total CVD
Glycemic Control Worse Than Thought in Adults With T1DM
Rates of both acute and chronic complications significantly increase with increasing HbA1c
September 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2019. This roundup includes the latest...
Nintedanib Slows Fibrosing Interstitial Lung Disease
Nintedanib linked to lower rate of decline in forced vital capacity versus placebo in phase 3 trial
Nivolumab Therapy Prolongs Survival in Advanced Melanoma
Overall survival at five years longer with nivolumab + ipilimumab, nivolumab alone versus ipilimumab
Heart Disease May Up Risk for Allopurinol-Linked Cutaneous AEs
Risk for hospital admission increased for allopurinol-associated severe cutaneous adverse reactions
Recommendations Updated for Management of Pediatric ADHD
Recommendations include screening for comorbid conditions, understanding ADHD is chronic condition
